Telezen MD Review: What Its GLP-1 Documentation Establishes—and What It Doesn’t

A published price is evidence of an offer, not evidence that a treatment will produce a particular result. That distinction matters at Telezen MD, where detailed descriptions of compounded semaglutide and tirzepatide sit alongside clinical credentials, microdosing promotions and a conditional weight-loss guarantee. The useful question is not simply whether the website mentions research. It is which claims its documents support, which require independent clinical evidence, and which remain unresolved before a patient pays.

The public documentation consulted October 19, 2026, describes a U.S. telehealth platform with online intake, clinician review, pharmacy fulfillment and continuing support. It also reveals meaningful differences between prominent sales language and purchase policies. This review separates those documentary findings from the broader evidence on GLP-1 medicines. It does not independently verify licenses, test medication quality or measure Telezen MD patients’ outcomes.

At a glance

Standard injectable plans: Compounded semaglutide is advertised at $168 billed monthly or $297 every three months; compounded tirzepatide at $268 billed monthly or $597 every three months.
Sources: [12]
Clinical access is conditional: Submitting intake does not guarantee a provider-patient relationship or prescription. Services are restricted to U.S. residents age 18 or older.
Sources: [11]
Independent pharmacy fulfillment: The terms say Telezen MD does not manufacture, compound, dispense or ship medication; independent third-party 503A pharmacies fulfill prescriptions, and patients do not choose the pharmacy.
Sources: [11]
Refund language conflicts: The FAQ promises a full refund when treatment is unsuitable; the refund policy permits a $35 deduction after a completed consultation and states a general nonrefundable 4% processing fee.
Sources: [8] [6]
Evidence boundary: Telezen MD acknowledges that compounded medicines are not FDA reviewed or approved for safety or efficacy. Published drug trials do not establish outcomes for its service or compounded preparations.
Sources: [12] [1] [3] [4]

Start with what kind of evidence the website provides

Telezen MD’s terms identify the operator as Telezen MD, LLC, a Florida limited liability company. Its role is to connect patients with licensed healthcare providers rather than guarantee treatment upon enrollment. That distinction gives the intake form a narrower meaning than a completed clinical visit: the terms explicitly say submitting it does not ensure either a provider-patient relationship or a prescription. These are documented service boundaries, not evidence about effectiveness.

The site identifies Ozita Cooper, MD, as dual board-certified in obesity medicine and emergency medicine, naming the American Board of Obesity Medicine and American Board of Emergency Medicine. Its FAQ also claims LegitScript certification and relationships exclusively with U.S.-licensed providers and licensed U.S. pharmacies. Those are attributable company statements. The consulted material does not independently verify the certifications, individual licenses or pharmacy quality controls.

This distinction is central to what public provider documents can prove. A team biography can identify a claimed credential; it cannot substitute for an outcome study. Likewise, an advertised support feature establishes what the company offers, not how consistently patients receive it. Telezen MD supplies substantial operational detail, but the consulted documentation does not establish a provider-specific rate of weight loss, adverse effects or successful long-term follow-up.

Sources: [11] [7] [8]

Compounded treatment is not the same evidence question as an approved product

The standard treatment page advertises injectable compounded semaglutide and tirzepatide. The FAQ also describes branded and compounded options when appropriate and legally permitted, but it does not guarantee a particular brand or formulation. The consulted pages do not establish which branded products are currently available or their prices. Telezen MD expressly acknowledges that compounded medications are not reviewed or approved by FDA for safety or efficacy.

FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. FDA recommends using compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. That recommendation is not a categorical conclusion about every patient or this platform. Nonapproval alone also does not demonstrate clinical inequivalence. Our guide to approved medicines and compounded preparations explains why these questions must remain separate.

The broader trial literature cannot fill the provider-specific gap. STEP 1 and SURMOUNT-1 were studies of defined subcutaneous drug regimens, not Telezen MD, its pharmacy preparations or microdosing plans. The company’s promotional claims about fewer adverse effects with microdosing, permanent results or behavioral-program benefits are not established by the consulted pages. Its microdosing page itself acknowledges that most cited trials studied standard protocols. The distinction between clinical trials and company performance reports is especially important here.

Sources: [12] [8] [10] [1] [3] [4]

Read the prices as billing structures, not interchangeable monthly figures

Telezen MD’s headline price starts at $99 per month for GLP-1 injections with medication, physician care and shipping included. Its price grid ties that figure specifically to compounded semaglutide at $297 every three months. The alternative is $168 billed monthly. Standard compounded tirzepatide costs $268 billed monthly or $597 every three months, advertised as $199 per month. These are different payment intervals, not four-week prices or evidence of a guaranteed medication quantity.

The microdosing page has separate prices and a more explicit payment disclosure. It describes monthly equivalents as estimates, says multi-month plans are paid in full at checkout or through buy-now-pay-later options, and warns that actual pricing may vary with the prescribed medication and treatment plan. It mentions three- and six-month compounded plans, while the FAQ also lists twelve-month plans. The consulted material does not provide complete six- or twelve-month prices or financing terms.

The $100 first-order promotion uses code WELCOME100, but its restrictions and compatibility with other offers are not clarified. More importantly, the refund policy says all orders carry a currently 4% nonrefundable processing fee charged at purchase. Buyers should obtain the actual checkout total rather than assume the displayed plan price is the entire transaction. The table preserves the advertised microdosing equivalents without treating their rounded figures as exact monthly installments.

Advertised plan prices and the payment distinctions that matter
Offering	Monthly option	Quarterly option and conditions
Standard compounded semaglutide injection	$168 billed monthly	$297 every three months; advertised as $99/month
Standard compounded tirzepatide injection	$268 billed monthly	$597 every three months; advertised as $199/month
Semaglutide microdosing plan	$98/month displayed	$248 quarterly; advertised estimated equivalent $82/month
Tirzepatide microdosing plan	$168/month displayed	$448 quarterly; advertised estimated equivalent $149/month
Microdosing multi-month payment disclosure	Separate from monthly options	Paid in full at checkout or through financing; actual prescribed-plan pricing may vary

Sources: [12] [10] [8] [6]

Eligibility leads to review—not automatic approval

The service is limited to adults at least 18 years old who reside in the United States. The FAQ advertises GLP-1 treatment in all 50 states, subject to medical eligibility and state regulations. Its intake collects health history, current medications, symptoms, goals and relevant lifestyle factors. Geographic reach therefore describes a potential service area, not assurance that every applicant in every state can obtain a particular medication or formulation.

As general eligibility guidance, Telezen MD mentions BMI of 27 or higher with at least one weight-related health consideration, or other clinical indications under current guidelines. It explicitly says meeting a BMI threshold does not guarantee approval. Its FAQ says laboratory requirements depend on therapy and medical history: some treatments may be prescribed from symptoms and history, while others require testing. The consulted pages do not establish laboratory prices or a universal testing schedule.

The standard page describes clinician review and a possible prescription typically within 24 hours. The FAQ instead frames review as approximately one business day. Neither establishes an immediate decision or guaranteed prescription. Before paying, a useful question is which clinician will conduct the evaluation, whether further information or testing could be needed, and what happens financially if review ends without a prescription. Telezen MD’s own refund documents do not give a fully consistent answer to that last question.

Sources: [11] [8] [12]

The pharmacy and delivery chain has separate responsibilities

Telezen MD’s terms say it does not manufacture, compound, dispense or ship medications. Instead, prescriptions are fulfilled by independent, licensed third-party 503A compounding pharmacies. Patients do not select the dispensing pharmacy, and pharmacy partners may change for clinical, operational or regulatory reasons. The consulted documentation does not name the pharmacy that would fill an individual order. Its privacy policy permits sharing information with clinicians for evaluation and independent pharmacies for prescription fulfillment.

Delivery descriptions differ. The standard page describes overnight shipping after preparation, while the FAQ allows approximately one business day for review, up to three business days for compounding if required, and approximately two business days after shipment. Medication type, pharmacy volume and holidays may change that timeline. Neither description means next-day arrival after completing intake. Advertised expedited shipping is an included service, not a documented end-to-end delivery guarantee.

The FAQ says some medicines travel with insulation and cold packs. The refund policy requires delivery problems to be reported within two business days of the marked delivery date; later claims are ineligible for replacement or reshipment. FDA separately advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or pharmacy. Our guide to cold-chain and delivery claims explains why packaging statements alone cannot resolve a particular shipment concern.

Sources: [11] [5] [12] [8] [6] [1]

Included support is documented more clearly than its clinical results

The standard plan includes provider review, medication, necessary supplies such as syringes and alcohol swabs, and free expedited shipping. It also includes unlimited provider messaging and concierge assistance by call or text. The FAQ says patients can send secure portal messages at any time, with provider responses typically within 24 hours. That is a stated response expectation, not immediate availability, and it should not be read as round-the-clock live clinical assessment.

Educational content and community access are available through a mobile application while a patient remains actively enrolled in a Telezen MD medical therapy. This defines an access benefit and its endpoint; it does not establish how much education an individual receives or whether the community improves outcomes. NIDDK describes follow-up as involving treatment response and tolerability, not simply renewed payments. The public material does not document an outcome-based follow-up schedule for every plan.

Financial support claims also need qualification. Telezen MD does not accept insurance. Its microdosing page advertises FSA/HSA acceptance and Klarna, Afterpay or Affirm, while the refund policy says only some services may qualify for FSA/HSA reimbursement and makes patients responsible for confirming eligibility. Neither a payment logo nor an acceptance statement establishes that a particular expense qualifies. Financing costs and terms also remain unprovided in the consulted documentation.

Sources: [12] [8] [10] [6] [2]

Cancellation flexibility does not settle refund eligibility

The standard sales page promises portal controls to pause, delay or cancel, with no contracts, membership fees or cancellation hassle. The refund policy is narrower: cancellation requests must be emailed to support@telezenmd.com within 12 hours of placing an order. These statements address different things. Ending future participation does not necessarily reverse an order already underway, and the consulted pages do not clearly establish automatic-renewal mechanics, renewal cutoff dates or refunds for unused prepaid periods.

The refund policy also contains competing processing cutoffs. One provision allows a refund when cancellation succeeds before pharmacy compounding begins, minus applicable fees. Another makes an order final and nonrefundable once any processing begins, including provider review, except under the 180-day guarantee. A separate provision deducts a nonrefundable $35 doctor visit fee if clinical review has occurred before cancellation. These clauses leave uncertainty about precisely when an otherwise timely request loses refund eligibility.

There is an additional direct conflict for rejected applicants. The FAQ promises a full refund if a clinician finds treatment inappropriate or unsafe. The refund policy instead permits deducting $35 after a completed consultation and separately states the general 4% nonrefundable processing fee. A reader should request a written explanation of the amount returned after denial, cancellation and completed review. The documentation does not justify assuming the most generous wording will govern every transaction.

Sources: [12] [6] [8]

The 180-day guarantee is a conditional financial remedy

Telezen MD’s guarantee does not promise a particular amount of weight loss. It offers possible reimbursement of medication fees after 180 consecutive days of full participation without any measurable weight loss. Any measurable loss eliminates eligibility, and the $35 doctor visit fee remains nonrefundable. This is therefore not evidence of average effectiveness or a broad satisfaction guarantee. Its trigger is much narrower than dissatisfaction with the amount or pace of change.

Required records include a timestamped starting weight within seven days of program commencement, monthly weigh-ins for six months and a final 180-day weigh-in, all using the same scale. A claim must be submitted within 14 days of completing the program. Telezen MD reserves the right to reject claims for noncompliance, inconsistent documentation or suspected fraud. Approved refunds are processed within 30 business days to the original payment method; that does not guarantee bank receipt within that period.

The guarantee’s documentation requirements make recordkeeping important from enrollment, rather than something to reconstruct at six months. For clarification, the published contact paths are support@telezenmd.com and 1 888-775-9343; the listed address is 2999 NE 191st Street, Suite 330, Aventura, Florida 33180. Those channels also provide a way to request the dispensing pharmacy’s identity and written answers about fees before purchase. Contact availability itself does not establish how a disputed claim will be resolved.

Sources: [6] [9]

Questions & answers

Is Telezen MD’s $99 semaglutide offer billed monthly?

The standard price grid attaches $99 per month to $297 billed every three months for compounded injectable semaglutide. A separate $168 monthly-billed option is advertised. Do not confuse that offer with the microdosing page’s estimated monthly equivalents and separate upfront-or-financing disclosure. Confirm the checkout total, processing fee and applicable promotion before paying.

Sources: [12] [10] [6]

Can I choose which pharmacy fills my Telezen MD prescription?

Not under the published terms. Telezen MD says pharmacy assignment depends on clinical appropriateness, availability and operational factors, and partners can change. The consulted documentation does not identify the establishment that would fill your prescription. Ask for that pharmacy’s identity and contact information rather than treating the platform’s general licensing claims as identification of a specific dispenser.

Sources: [11]

Will Telezen MD refund me if I am not approved?

Its documents disagree about the amount. The FAQ promises a full refund when treatment is inappropriate or unsafe. The refund policy allows a $35 deduction after a completed consultation and also states a general nonrefundable 4% processing fee. Obtain a written explanation of which deductions apply to an unsuccessful application before relying on the full-refund statement.

Sources: [8] [6]

Does unlimited messaging mean immediate access to a clinician?

No immediate response is promised. Telezen MD includes unlimited provider messaging, and its FAQ says portal messages can be sent anytime with responses typically within 24 hours. Concierge assistance by call or text is also included. Those are useful access features, but neither establishes continuous live clinical availability or a guaranteed response time for every message.

Sources: [12] [8]

Does the weight-loss guarantee validate Telezen MD’s results?

No. It defines a possible financial remedy, not a clinical study or success rate. Eligibility requires no measurable loss after 180 consecutive days of full participation, specified weight records and a timely claim. Any measurable loss disqualifies the claim. Medication fees may be refundable, but the $35 visit fee is excluded, and approval remains subject to review.

Sources: [6]

What should I do if a Telezen MD injectable shipment arrives warm?

FDA advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Telezen MD separately requires delivery issues to be reported within two business days of the marked delivery date for replacement or reshipment eligibility. Its statement that some products use insulation and cold packs does not resolve the condition of an individual delivery.

Sources: [1] [6] [8]

Our assessment

Telezen MD documents a recognizable care pathway and concrete benefits: clinical review, compounded injectable plans, supplies, shipping and ongoing messaging. Its published prices are useful, provided billing intervals and additional fees remain visible. The weaker points are evidence and consistency: company-specific outcomes are not established, dispensing pharmacies are unnamed, and refund language conflicts across pages. Credentials, microdosing promotions and a conditional guarantee should not substitute for product-specific evidence or clear purchase terms. The most productive next step is written clarification of the prescribed formulation, pharmacy, total charge, follow-up arrangements and refund rules—not an assumption that marketing language resolves those questions.

Visit Telezen MD’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Telezen MD Review: What Its GLP-1 Documentation Establishes—and What It Doesn’t

At a glance

01Start with what kind of evidence the website provides

02Compounded treatment is not the same evidence question as an approved product

03Read the prices as billing structures, not interchangeable monthly figures

04Eligibility leads to review—not automatic approval

05The pharmacy and delivery chain has separate responsibilities

06Included support is documented more clearly than its clinical results

07Cancellation flexibility does not settle refund eligibility

08The 180-day guarantee is a conditional financial remedy